持続的腎代替療法の世界市場規模調査＆予測、製品別、モダリティ別、年齢層別、エンドユーザー別、地域別分析、2023-2030年

世界の持続的腎代替療法（CRRT）市場は、2022年に約13億米ドルと評価され、予測期間2023-2030年には8.1%以上の健全な成長率で成長すると予測されています。

持続的腎代替療法（CRRT）は、急性腎障害（AKI）に直面している重症患者の腎機能を管理する上で極めて重要な治療法です。この方法は、特に血行動態が不安定な患者にとって有益な24時間連続透析療法です。CRRTは、血液濾過、血液透析、またはその両方の組み合わせなどのプロセスを通じて血液から溶質を徐々に除去するもので、ICU内で継続的に投与されるため、従来の腎代替療法とは異なります。CRRT市場は、世界のICU入室の増加、敗血症に関連したAKI症例の急増、断続的な血液浄化に対するCRRTの臨床的優位性の高まり、糖尿病や高血圧の有病率の上昇などの要因により、大きな成長を遂げています。

さらに、重症治療室における患者数の世界の増加、特に急性腎障害（AKI）を経験する患者の増加が、主に市場の成長を支えています。AKIは集中治療室（ICU）で広く見られる懸念であり、CRRTはこの合併症を持つ重症患者の管理に効果があることが証明されています。例えば、米国疾病予防管理センター（CDC）の最近のデータによると、米国では約170万人の成人が敗血症を発症しており、敗血症に関連するAKIとそれに伴う罹患率および死亡率の管理に不可欠な要素としてCRRTの需要が高まっています。また、2020年10月の国立生物工学情報センター（NCBI）の論文によると、米国では入院患者の13％から18％が急性腎障害に罹患しています。この治療法は主に、がん、糖尿病、心臓手術などの重症患者に投与され、患者の病状に応じて24時間またはそれ以上の間、重要なサポートを提供します。経済社会省によると、2019年、世界の65歳以上の人口は7億300万人に達しました。また、高齢者の数は2050年までに15億人に増加すると予想されています。AKIの流行と世界の高齢者人口の増加は、CRRTの需要増加に寄与しています。高血圧、がん、心臓病、糖尿病、脳卒中など、加齢に関連した健康状態によるICU入室の急増は、急性および慢性の健康問題の管理におけるこの療法の重要性を浮き彫りにしています。世界の高齢化人口の増加が予測されることから、ヘルスケアのニーズを満たすためのCRRTの役割が拡大していることがさらに強調されています。これらの要因がCRRT市場の継続的な拡大を後押ししています。さらに、CRRTが単純な腎代替療法から多臓器支援療法へと発展し、CRRTの安全性と有効性のプロファイルを確立するための研究活動が重視されるようになったことで、予測期間中にさまざまな有利な機会がもたらされます。しかし、新興国市場における標準的な治療ガイドラインの欠如とCRRTの高い複雑性が、2023-2030年の予測期間を通じて市場の成長を妨げています。

持続的腎代替療法の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、集中治療室（ICU）患者における急性腎障害（AKI）の有病率の高さ、治療関連製品に対する旺盛な需要が他地域を上回っていること、医療インフラが整備されていることから、2022年の市場を独占しました。さらに、同地域は規制機関からの支援増加の恩恵を受けており、製品メーカーの存在感が強いことも大きな市場シェアに寄与しています。例えば、2022年4月にBaxter International Inc.は、PrisMaxまたはPrismaflexコントロールユニットと互換性のあるSTセットについて、米国食品医薬品局（FDA）から510（k）認可を取得しました。一方、アジア太平洋地域は予測期間中最も速いCAGRで成長すると予想されています。糖尿病、慢性腎臓病（CKD）、高血圧の罹患率が上昇していることが、この地域の市場需要を大きく押し上げています。さらに、医療費の増加と研究開発投資の増加が医療市場の繁栄に寄与しており、これが予測される数年間の市場拡大をさらに後押ししています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 持続的腎代替療法の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 持続的腎代替療法の世界市場力学

• 持続的腎代替療法市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 急性腎障害（AKI）の発生率の増加
    • 断続的血液浄化療法に対するCRRTの臨床的優位性の高まり
  • 市場の課題
    • 発展途上国における標準治療ガイドラインの欠如
    • CRRTの高い複雑性
  • 市場機会
    • 単純な腎代替療法から多臓器支持療法へのCRRTの発展
    • CRRTの安全性と有効性プロファイルを確立するための調査活動の重点化

第4章 世界の持続的腎代替療法市場産業分析

• ポーターのファイブフォースモデル
• ポーターのファイブフォース影響分析
• PEST分析
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 持続的腎代替療法の世界市場：製品別

• 市場スナップショット
• 持続的腎代替療法の世界市場：製品別、実績 - ポテンシャル分析
• 持続的腎代替療法の世界市場：製品別推定・予測 2020-2030年
• 持続的腎代替療法市場：サブセグメント別分析
  • 透析液および交換液
  • ディスポーザブル（使い捨て品）
  • 血液フィルター
  • 血液ラインセットとチューブ
  • その他の消耗品
  • CRRTシステム

第6章 持続的腎代替療法の世界市場：モダリティ別

• 市場スナップショット
• 持続的腎代替療法の世界市場：モダリティ別、実績 - ポテンシャル分析
• 持続的腎代替療法の世界市場：モダリティ別推定・予測2020～2030年
• 持続的腎代替療法市場：サブセグメント分析
  • 持続的動静脈血液濾過療法（CVVH）
  • 持続的動静脈血液濾過療法（CVVHDF）
  • 持続的静脈血液透析（CVVHD）
  • 緩徐式持続限外濾過（SCUF）

第7章 持続的腎代替療法の世界市場：年齢層別

• 市場スナップショット
• 持続的腎代替療法の世界市場：年齢層別、実績 - ポテンシャル分析
• 持続的腎代替療法の世界市場：年齢層別推定・予測 2020-2030年
• 持続的腎代替療法市場：サブセグメント分析
  • 成人
  • 小児科／新生児

第8章 持続的腎代替療法市場：エンドユーザー別

• 市場スナップショット
• 持続的腎代替療法の世界市場：エンドユーザー別、実績-潜在能力分析
• 持続的腎代替療法の世界市場：エンドユーザー別推定・予測2020～2030年
• 持続的腎代替療法市場：サブセグメント分析
  • 病院
  • 外来医療
  • 在宅医療
  • その他

第9章 持続的腎代替療法の世界市場：地域別分析

• 主要国
• 主な新興国
• 持続的腎代替療法市場：地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Baxter
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • B Braun SE
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.（Asahi Kasei Corporation）
  • NIPRO Corporation
  • Toray Medical Co, Ltd.（Toray Industries, Inc.）
  • Nikkiso Co., Ltd.
  • Medtronic PLC
  • Medica SpA
  • Medical Components, Inc.

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Continuous Renal Replacement Therapy Market, report scope
• TABLE 2. Global Continuous Renal Replacement Therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Continuous Renal Replacement Therapy Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 4. Global Continuous Renal Replacement Therapy Market estimates & forecasts by Modality 2020-2030 (USD Billion)
• TABLE 5. Global Continuous Renal Replacement Therapy Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
• TABLE 6. Global Continuous Renal Replacement Therapy Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 7. Global Continuous Renal Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Continuous Renal Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Continuous Renal Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Continuous Renal Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Continuous Renal Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Continuous Renal Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Continuous Renal Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Continuous Renal Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Continuous Renal Replacement Therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. Global Continuous Renal Replacement Therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 18. U.S. Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. U.S. Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 21. Canada Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. Canada Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 24. UK Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. UK Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 27. Germany Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. Germany Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 30. France Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. France Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 33. Italy Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Italy Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 36. Spain Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. Spain Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 39. RoE Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. RoE Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 42. China Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. China Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 45. India Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. India Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 48. Japan Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. Japan Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 51. South Korea Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. South Korea Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 54. Australia Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. Australia Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. RoAPAC Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 60. Brazil Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Brazil Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 63. Mexico Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. Mexico Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 66. RoLA Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. RoLA Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. Saudi Arabia Continuous Renal Replacement Therapy Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 69. South Africa Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. RoMEA Continuous Renal Replacement Therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global Continuous Renal Replacement Therapy Market
• TABLE 72. List of primary sources, used in the study of global Continuous Renal Replacement Therapy Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Continuous Renal Replacement Therapy Market, research methodology
• FIG 2. Global Continuous Renal Replacement Therapy Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Continuous Renal Replacement Therapy Market, key trends 2022
• FIG 5. Global Continuous Renal Replacement Therapy Market, growth prospects 2023-2030
• FIG 6. Global Continuous Renal Replacement Therapy Market, porters 5 force model
• FIG 7. Global Continuous Renal Replacement Therapy Market, pest analysis
• FIG 8. Global Continuous Renal Replacement Therapy Market, value chain analysis
• FIG 9. Global Continuous Renal Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Continuous Renal Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Continuous Renal Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Continuous Renal Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Continuous Renal Replacement Therapy Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Continuous Renal Replacement Therapy Market, regional snapshot 2020 & 2030
• FIG 15. North America Continuous Renal Replacement Therapy Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Continuous Renal Replacement Therapy Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Continuous Renal Replacement Therapy Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Continuous Renal Replacement Therapy Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Continuous Renal Replacement Therapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Continuous Renal Replacement Therapy Market is valued at approximately USD 1.3 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.1% during the forecast period 2023-2030. Continuous Renal Replacement Therapy (CRRT) is a crucial intervention in managing renal function for critically ill patients facing Acute Kidney Injury (AKI). This method provides a continuous 24-hour dialysis therapy that is particularly beneficial for patients experiencing hemodynamic instability. CRRT involves the gradual removal of solutes from the blood through processes such as hemofiltration, hemodialysis, or a combination of both, and it is administered continuously within an ICU setting, distinguishing it from conventional renal replacement therapies. The market for CRRT has witnessed significant growth due to factors such as the increasing ICU admissions globally, a surge in sepsis-related AKI cases, the growing clinical advantage of CRRT over intermittent blood purification, and the rising prevalence of diabetes and hypertension.

In addition, the rising number of patients in critical care units globally, particularly those experiencing Acute Kidney Injury (AKI) is primarily supporting the market growth. AKI is a prevalent concern in Intensive Care Units (ICUs), and CRRT has proven impactful in managing critically ill patients with this complication. For instance, recent data from the Centers for Disease Control and Prevention (CDC) indicates that around 1.7 million adults in the U.S. develop sepsis, contributing to a high demand for CRRT as a vital component in managing sepsis-associated AKI with its associated morbidity and mortality rates. Also, a National Center for Biotechnology Information (NCBI) article from October 2020 states that between 13% and 18% of hospitalized patients in the United Kingdom suffer from acute renal damage. The therapy is primarily administered to patients with severe conditions such as cancer, diabetes, and cardiac surgery, providing crucial support for 24 hours or longer, depending on the patient's medical condition. According to the Department of Economic and Social Affairs, in 2019, the world's population of people aged 65 and up totalled 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. The prevalence of AKI and the growing geriatric population worldwide contribute to the increasing demand for CRRT. The surge in ICU admissions due to age-related health conditions, such as hypertension, cancer, heart disease, diabetes, and stroke, highlights the therapy's importance in managing acute and chronic health issues. The projected rise in the global aging population further emphasizes the expanding role of CRRT in meeting healthcare needs. These factors collectively drive the continuous expansion of the CRRT Market. Moreover, the development of CRRT from simple renal replacement treatment to multi-organ support therapy, as well as the rising emphasis on the research activities to establish the safety and efficacy profile of CRRT presents various lucrative opportunities over the forecast years. However, the lack of standard treatment guidelines in developing nations and the high complexity of CRRT are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Continuous Renal Replacement Therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high prevalence of Acute Kidney Injury (AKI) among Intensive Care Unit (ICU) patients, robust demand for therapy-related products surpassing other regions, and the presence of well-established healthcare infrastructure. Furthermore, the region benefits from increasing support from regulatory bodies, and the strong presence of product manufacturers contributes to its significant market share. For instance, in April 2022, Baxter International Inc. obtained the 510(k) clearance from the U.S. Food and Drug Administration for its ST Set utilized in this therapy, compatible with PrisMax or Prismaflex control units. Whereas, Asia Pacific is expected to grow at the fastest CAGR over the forecast years. The rising incidence rates of diabetes, Chronic Kidney Disease (CKD), and hypertension are significantly propelling the market demand across the region. Additionally, increased healthcare expenditure and growing research and development investments contribute to the flourishing healthcare market, which is further supporting the market expansion over the anticipated years.

Major market players included in this report are:

• Baxter
• B Braun SE
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
• NIPRO Corporation (
• Toray Medical Co, Ltd. (Toray Industries, Inc.)
• Nikkiso Co., Ltd.
• Medtronic PLC
• Medica SpA
• Medical Components, Inc.

Recent Developments in the Market:

• In March 2022, Nipro, a prominent manufacturer of renal products, unveiled the full-scale commercial launch of SURDIAL DX, a cutting-edge hemodialysis system meticulously crafted to deliver optimal dialysis treatment.
• In April 2022, Baxter International announced that the ST set used in continuous renal replacement treatment has received FDA (510k) approval. This pre-configured extracorporeal device works in perfect harmony with Prismaflex or PrisMax, using a semipermeable membrane to cleanse blood..
• In August 2022, Fresenius Medical Care North America launched the Speedswap system designed for use with the NxStage System One featuring NxView. This innovation aims to minimize downtime, decrease treatment costs, and alleviate nursing burdens associated with this therapy in critical care settings.

Global Continuous Renal Replacement Therapy Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Modality, Age Group, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Dialysates and Replacement Fluids
• Disposables
• Hemofilters
• Bloodline Sets & Tubes
• Other Disposables
• CRRT Systems

By Modality:

• Continuous venovenous hemofiltration (CVVH)
• Continuous venovenous hemodiafiltration (CVVHDF)
• Continuous venovenous haemodialysis (CVVHD)
• Slow continuous ultrafiltration (SCUF)

By Age Group:

• Adults
• Pediatrics /Neonates

By End User:

• Hospital
• Ambulatory care
• Homecare
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Continuous Renal Replacement Therapy Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Continuous Renal Replacement Therapy Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3. Continuous Renal Replacement Therapy Market, by Modality, 2020-2030 (USD Billion)
  • 1.2.4. Continuous Renal Replacement Therapy Market, by Age Group, 2020-2030 (USD Billion)
  • 1.2.5. Continuous Renal Replacement Therapy Market, by End User, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Continuous Renal Replacement Therapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Continuous Renal Replacement Therapy Market Dynamics

• 3.1. Continuous Renal Replacement Therapy Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of Acute Kidney Injury (AKI)
    • 3.1.1.2. Growing clinical advantage of CRRT over intermittent blood purification
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of standard treatment guidelines in developing nations
    • 3.1.2.2. High complexity of CRRT
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Development of CRRT from simple renal replacement treatment to multi-organ support therapy
    • 3.1.3.2. Rising emphasis on the research activities to establish safety and efficacy profile of CRRT

Chapter 4. Global Continuous Renal Replacement Therapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Continuous Renal Replacement Therapy Market, by Product

• 5.1. Market Snapshot
• 5.2. Global Continuous Renal Replacement Therapy Market by Product, Performance - Potential Analysis
• 5.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 5.4.1. Dialysates and Replacement Fluids
  • 5.4.2. Disposables
  • 5.4.3. Hemofilters
  • 5.4.4. Bloodline Sets & Tubes
  • 5.4.5. Other Disposables
  • 5.4.6. CRRT Systems

Chapter 6. Global Continuous Renal Replacement Therapy Market, by Modality

• 6.1. Market Snapshot
• 6.2. Global Continuous Renal Replacement Therapy Market by Modality, Performance - Potential Analysis
• 6.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
• 6.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 6.4.1. Continuous venovenous hemofiltration (CVVH)
  • 6.4.2. Continuous venovenous hemodiafiltration (CVVHDF)
  • 6.4.3. Continuous venovenous haemodialysis (CVVHD)
  • 6.4.4. Slow continuous ultrafiltration (SCUF)

Chapter 7. Global Continuous Renal Replacement Therapy Market, by Age Group

• 7.1. Market Snapshot
• 7.2. Global Continuous Renal Replacement Therapy Market by Age Group, Performance - Potential Analysis
• 7.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
• 7.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 7.4.1. Adults
  • 7.4.2. Pediatrics /Neonates

Chapter 8. Continuous Renal Replacement Therapy Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Continuous Renal Replacement Therapy Market by End User, Performance - Potential Analysis
• 8.3. Global Continuous Renal Replacement Therapy Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 8.4. Continuous Renal Replacement Therapy Market, Sub Segment Analysis
  • 8.4.1. Hospital
  • 8.4.2. Ambulatory care
  • 8.4.3. Homecare
  • 8.4.4. Others

Chapter 9. Global Continuous Renal Replacement Therapy Market, Regional Analysis

• 9.1. Top Leading Countries
• 9.2. Top Emerging Countries
• 9.3. Continuous Renal Replacement Therapy Market, Regional Market Snapshot
• 9.4. North America Continuous Renal Replacement Therapy Market
  • 9.4.1. U.S. Continuous Renal Replacement Therapy Market
    • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2. Modality breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3. Age Group breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
  • 9.4.2. Canada Continuous Renal Replacement Therapy Market
• 9.5. Europe Continuous Renal Replacement Therapy Market Snapshot
  • 9.5.1. U.K. Continuous Renal Replacement Therapy Market
  • 9.5.2. Germany Continuous Renal Replacement Therapy Market
  • 9.5.3. France Continuous Renal Replacement Therapy Market
  • 9.5.4. Spain Continuous Renal Replacement Therapy Market
  • 9.5.5. Italy Continuous Renal Replacement Therapy Market
  • 9.5.6. Rest of Europe Continuous Renal Replacement Therapy Market
• 9.6. Asia-Pacific Continuous Renal Replacement Therapy Market Snapshot
  • 9.6.1. China Continuous Renal Replacement Therapy Market
  • 9.6.2. India Continuous Renal Replacement Therapy Market
  • 9.6.3. Japan Continuous Renal Replacement Therapy Market
  • 9.6.4. Australia Continuous Renal Replacement Therapy Market
  • 9.6.5. South Korea Continuous Renal Replacement Therapy Market
  • 9.6.6. Rest of Asia Pacific Continuous Renal Replacement Therapy Market
• 9.7. Latin America Continuous Renal Replacement Therapy Market Snapshot
  • 9.7.1. Brazil Continuous Renal Replacement Therapy Market
  • 9.7.2. Mexico Continuous Renal Replacement Therapy Market
• 9.8. Middle East & Africa Continuous Renal Replacement Therapy Market
  • 9.8.1. Saudi Arabia Continuous Renal Replacement Therapy Market
  • 9.8.2. South Africa Continuous Renal Replacement Therapy Market
  • 9.8.3. Rest of Middle East & Africa Continuous Renal Replacement Therapy Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Company 1
  • 10.1.2. Company 2
  • 10.1.3. Company 3
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Baxter
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Recent Developments
  • 10.3.2. B Braun SE
  • 10.3.3. Fresenius Medical Care AG & Co. KGaA
  • 10.3.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
  • 10.3.5. NIPRO Corporation
  • 10.3.6. Toray Medical Co, Ltd. (Toray Industries, Inc.)
  • 10.3.7. Nikkiso Co., Ltd.
  • 10.3.8. Medtronic PLC
  • 10.3.9. Medica SpA
  • 10.3.10. Medical Components, Inc.

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption